You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Ticlopidine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for ticlopidine hydrochloride
US Patents:0
Tradenames:2
Applicants:9
NDAs:10
Drug Master File Entries: 6
Raw Ingredient (Bulk) Api Vendors: 113
Clinical Trials: 39
Patent Applications: 2,792
What excipients (inactive ingredients) are in ticlopidine hydrochloride?ticlopidine hydrochloride excipients list
DailyMed Link:ticlopidine hydrochloride at DailyMed
Recent Clinical Trials for ticlopidine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kafrelsheikh UniversityPhase 3
Ain Shams UniversityPhase 3
Janssen Research & Development, LLCPhase 1

See all ticlopidine hydrochloride clinical trials

US Patents and Regulatory Information for ticlopidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075149-001 Aug 20, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Inc TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075526-001 Sep 26, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075326-001 Aug 20, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075316-001 Nov 2, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ticlopidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 ⤷  Sign Up ⤷  Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.